Previous Article | Next Article 
Journal of Clinical Microbiology, March 2009, p. 852-854, Vol. 47, No. 3
0095-1137/09/$08.00+0 doi:10.1128/JCM.01196-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
Necrotizing Fasciitis Caused by Haemophilus influenzae Type b in an Elderly Patient
Takashi Saito,1*
Hiromi Matsunaga,2
Yumi Matsumura,2
Hajime Segawa,3
Shunji Takakura,1
Miki Nagao,1
Yoshitsugu Iinuma,1
Yoshiki Miyachi,2 and
Satoshi Ichiyama1
Department of Infection Control and Prevention, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan,1
Department of Dermatology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan,2
Division of Critical Care Medicine, Kyoto University Hospital, Kyoto, Japan3
Received 24 June 2008/
Returned for modification 20 August 2008/
Accepted 19 December 2008

ABSTRACT
Necrotizing fasciitis caused by
Haemophilus influenzae type
b is a rare infection of the skin and soft tissues. The only
previously reported case involved a healthy infant. We report
herein the case of an 81-year-old Japanese woman with diabetes
mellitus who developed necrotizing fasciitis caused by
H. influenzae type b.

CASE REPORT
An 81-year-old Japanese woman presented to the outpatient dermatology
department at Kyoto University Hospital with painful swelling
of the left leg. She had a history of type II diabetes mellitus
and had not previously been vaccinated against
Haemophilus influenzae type b. Physical examination revealed swelling, erythema, purpura
of the left lower extremity, and hemorrhagic bullous lesions
of the left dorsum (Fig.
1). Swelling and erythema spread rapidly
to the left lower limb, and she became unconscious 1 h after
presentation. The patient was therefore transferred to the intensive
care unit.
Examination revealed the following: temperature, 36.4°C;
heart rate, 132 beats/min; respiratory rate, 24 breaths/min;
blood pressure, 107/88 mmHg. Laboratory examinations showed
the following: white blood cell count, 3.5
x10
9 cells/liter
with 3% segmented cells, 38% band cells, 22% metamyelocytes,
21% myelocytes, 15% lymphocytes, and 1% eosinophils; platelet
count, 34,000/liter; prothrombin time, 18.0 s; activated partial
thromboplastin time, 42.7 s; fibrinogen, 839 mg/dl; fibrin degradation
product, 2.4 µg/ml; aspartate aminotransferase level,
23 IU/liter; creatinine level, 4.7 mg/dl; C-reactive protein
level, 28.1 mg/dl. Blood gas analysis under room air revealed
the following: pH, 7.188; pCO
2, 31.6 mmHg; pO
2, 70.7 mmHg; HCO
3–,
11.8 mmol/liter; base excess, –15.2 mmol/liter.
Two sets of blood cultures, with BacT/Alert aerobic (FA) and anaerobic (FN) bottles (bioMérieux, Marcy l'Etoile, France), were performed. Bedside biopsy material from the affected area of the left lower extremity yielded gram-negative rods with polymorphonuclear leukocytes on Gram staining. Combination antibiotic therapy including meropenem (1 g/day divided into two doses) and minocycline (400 mg/day divided into two doses) adjusted to renal dysfunction was empirically started. Extensive debridement was performed 7 h after presentation. The subcutis, fascia, and muscles were totally necrotic. As complications of acute renal failure were also present, continuous hemodialysis was initiated.
On hospitalization day 2, all blood cultures obtained on admission revealed gram-negative rods on Gram staining. On hospitalization day 3, H. influenzae was isolated with the RapID NH system (Remel, Lenexa, KS) from all blood cultures and surgical specimens of bedside biopsy material and debrided tissue. Antibiotic susceptibility tests performed by the microdilution method with an MIC2000 system (Nagase, Tokyo, Japan) revealed the H. influenzae isolate to be susceptible to ampicillin (MIC, 0.5 µg/ml), cefotaxime (MIC, 0.25 µg/ml), clarithromycin (MIC,
0.25 µg/ml), meropenem (MIC,
0.12 µg/ml), and levofloxacin (MIC,
0.25 µg/ml) according to the criteria for interpretation defined by the Clinical and Laboratory Standards Institute (9). No H. influenzae isolates produced β-lactamase according to examination by the nitrocefin disk method (Cefinase; Becton Dickinson Microbiology Systems, Tokyo, Japan). A type b isolate was confirmed by using H. influenzae antisera a to f (Denka Seiken, Tokyo, Japan).
Necrotizing fasciitis was confirmed histopathologically with debrided tissue revealing necrosis from dermis to fascium, along with capillary thrombosis and polymorphonuclear leukocytic infiltration (Fig. 2). The patient was switched to cefotaxime (4 g/day divided into two doses) adjusted to renal dysfunction according to in vitro results of antibiotic susceptibility testing. The patient had received intravenous cefotaxime for a total of 28 days until 31 days after presentation. Extensive autografting was performed to close the wound 71 days after admission. The patient recovered fully and was discharged from the hospital 135 days after admission.
Necrotizing fasciitis is an infectious process that progressively
destroys the subcutaneous fascia and fat while relatively sparing
the underlying muscle (
14). Mixed aerobic and anaerobic microorganisms
or group A streptococci have generally been considered responsible
for necrotizing fasciitis (
13), and the condition is associated
with substantial morbidity and mortality in the absence of aggressive
surgical and antibiotic therapy (
7). A review of the English
literature revealed seven case reports of
Haemophilus-associated
necrotizing fasciitis (
1,
3-
5,
8,
11,
12). Among these cases
of necrotizing fasciitis associated with
H. influenzae, the
first case was of lower limb necrotizing fasciitis caused by
H. influenzae type b in a 13-month-old infant (
3). The second
case was caused by unencapsulated
H. influenzae in a 45-year-old
patient with insulin-dependent diabetes mellitus who developed
necrotizing fasciitis in the right gluteal region and lateral
thigh (
12). In the third case, fatal lower limb necrotizing
fasciitis was caused by
H. influenzae type f in a 65-year-old
patient with a history of hypertension, gout, and excessive
alcohol consumption (
8). The fourth case occurred in a 79-year-old
man with non-insulin-dependent diabetes, with craniofacial necrotizing
fasciitis occurring secondary to maxillary sinusitis from which
H. influenzae (type unknown) was isolated in association with
group A streptococci,
Staphylococcus aureus, and
Streptococcus pyogenes (
11). The fifth case occurred in a 19-month-old infant
with necrotizing fasciitis involving the parapharyngeal space,
from which nontypeable
H. influenzae was isolated in association
with
S. aureus,
Bacteroides fragilis, and
Peptostreptococcus species (
1). In the sixth case, necrotizing fasciitis was associated
with
H. aphrophilus in a 35-year-old patient; it was caused
by intravenous injection of a dissolved methylphenidate hydrochloride
tablet (
5). The final case involved cervical necrotizing fasciitis
caused by
H. aphrophilus in a 5-month-old infant (
4). Necrotizing
fasciitis caused by
H. influenzae type b thus appears rare.
The present case thus represents the first case of adult necrotizing
fasciitis caused by
H. influenzae type b.
In Japan, H. influenzae type b vaccination is not conducted routinely in childhood. The widespread use of effective conjugate vaccines has substantially decreased infections with H. influenzae type b (2, 10). Conversely, the incidence of invasive H. influenzae disease among persons over 65 years old and invasive nontypeable H. influenzae disease increased from 1996 to 2004 (6). The frequency of cases of H. influenzae type f involving necrotizing fasciitis has remained almost unchanged during this period (6). Whether necrotizing fasciitis caused by H. influenzae is becoming more common is therefore unclear.
Invasive H. influenzae disease has occurred in the extreme ages of life in patients with predisposing conditions such as an age of >65 years and diabetes mellitus (7). Diabetes mellitus is a clinical characteristic that may facilitate the development of necrotizing fasciitis (13). Our patient displayed predisposing factors such as old age (81 years), diabetes mellitus, and no vaccination against H. influenzae type b, allowing the development of necrotizing fasciitis caused by H. influenzae type b.
We reported the case of an 81-year-old Japanese woman with diabetes mellitus who developed necrotizing fasciitis caused by H. influenzae type b in which extensive debridement and antibiotic therapy were effective. Physicians should consider that invasive H. influenzae type b disease, including necrotizing fasciitis, can occur even in elderly patients.

FOOTNOTES
* Corresponding author. Mailing address: Department of Infection Control and Prevention, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan. Phone: 81-75-751-3503. Fax: 81-75-751-3233. E-mail:
saitota{at}kuhp.kyoto-u.ac.jp 
Published ahead of print on 30 December 2008. 

REFERENCES
1 - Bush, J. K., L. B. Givner, S. H. Whitaker, D. C. Anderson, and A. K. Percy. 1984. Necrotizing fasciitis of the parapharyngeal space with carotid artery occlusion and acute hemiplegia. Pediatrics 73:343-347.[Abstract/Free Full Text]
2 - Campos, J., M. Hernando, F. Román, M. Pérez-Vázquez, B. Aracil, J. Oteo, E. Lázaro, F. de Abajo, and the Group of Invasive Haemophilus Infections of the Autonomous Community of Madrid, Spain. 2004. Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. J. Clin. Microbiol. 42:524-529.[Abstract/Free Full Text]
3 - Collette, C. J., D. Southerland, and C. J. Corrall. 1987. Necrotizing fasciitis associated with Haemophilus influenzae type b. Am. J. Dis. Child. 141:1146-1148.[Abstract/Free Full Text]
4 - Cordeiro, A. M., A. Bousso, I. de Cassia, O. F. Fernandes, J. C. Fernandes, F. M. Elias, W. A. Jorge, B. Ejzenberg, and Y. Okay. 1997. Cervical necrotizing fasciitis in an infant caused by Haemophilus non influenzae. Infection 25:383-384.[CrossRef][Medline]
5 - Crawford, S. A., J. A. Evans, and G. E. Crawford. 1978. Necrotizing fasciitis associated with Haemophilus aphrophilus. Report of a case. Arch. Intern. Med. 138:1714-1715.[Abstract/Free Full Text]
6 - Dworkin, M. S., L. Park, and S. M. Borchardt. 2007. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons
65 years old. Clin. Infect. Dis. 44:810-816.[CrossRef][Medline] 7 - Green, R. J., D. C. Dafoe, and T. A. Raffin. 1996. Necrotizing fasciitis. Chest 110:219-229.[Abstract/Free Full Text]
8 - McLellan, E., K. Suvarna, and R. Townsend. 2008. Fatal necrotizing fasciitis caused by Haemophilus influenzae serotype f. J. Med. Microbiol. 57:249-251.[Abstract/Free Full Text]
9 - National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing; twelfth informational supplement. M100-S12. National Committee for Clinical Laboratory Standards, Wayne, PA.
10 - Peltola, H. 2000. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin. Microbiol. Rev. 13:302-317.[Abstract/Free Full Text]
11 - Raboso, E., M. T. Llavero, A. Rosell, and A. Martinez-Vidal. 1998. Craniofacial necrotizing fasciitis secondary to sinusitis. J. Laryngol. Otol. 112:371-372.[Medline]
12 - Stumvoll, M., and A. Fritsche. 1997. Necrotizing fasciitis caused by unencapsulated Haemophilus influenzae. Clin. Infect. Dis. 25:327.[Medline]
13 - Swartz, N. M., and M. S. Pasternack. 2005. Cellulitis and subcutaneous tissue infections, p. 1172-1194. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, PA.
14 - Wilhelm, M. R., and R. S. Edson. 2001. Skin and soft-tissue infections, p. 177-190. In W. R. Wilson and M. A. Sande (ed.), Current diagnosis & treatment in infectious diseases. McGraw-Hill, New York, NY.
Journal of Clinical Microbiology, March 2009, p. 852-854, Vol. 47, No. 3
0095-1137/09/$08.00+0 doi:10.1128/JCM.01196-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.